The document provides an overview of the Paramyxoviridae family, which includes various viruses that primarily affect the respiratory tract in humans and animals. Key viruses discussed include Measles, Respiratory Syncytial Virus, Parainfluenza Virus, Mumps, and Nipah Virus, detailing their characteristics, modes of transmission, symptoms, complications, diagnosis, and treatment options. The document emphasizes the importance of vaccination and supportive care in managing these viral infections.
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0 ratings0% found this document useful (0 votes)
4 views18 pages
16 +paramyxoviridae
The document provides an overview of the Paramyxoviridae family, which includes various viruses that primarily affect the respiratory tract in humans and animals. Key viruses discussed include Measles, Respiratory Syncytial Virus, Parainfluenza Virus, Mumps, and Nipah Virus, detailing their characteristics, modes of transmission, symptoms, complications, diagnosis, and treatment options. The document emphasizes the importance of vaccination and supportive care in managing these viral infections.
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 18
PARAMYXOVIRIDAE
Danielle Marie A. Allarey-Susa, RMT
Introduction • Pleomorphic, spherical or filamentous, Enveloped, Negative- sense, single-stranded RNA viruses • causes a variety of diseases, predominantly involving the respiratory tract, in humans, birds, and other animals in humans Viruses 1. Measles 2. Respiratory Syncytial virus 3. Parainfluenza Virus 4. Mumps 5. Nipah Virus Measles Virus Measles Virus • SF: Paramyxovirinae • G: Morbilivirus • “Rubeola virus” • Pleomorphic, enveloped, non-segmented single-stranded, negative sense RNA virus • MOT: person to person through aerosols/respiratory droplets • HALLMARK RASH: Koplik Spots • Initial Symptoms: • Cough • Coryza (nasal inflammation) • Conjunctivitis • Fever Measles Virus Complications • Severe Outcomes: • Immunosuppression • Central Nervous System (CNS) complications, including: • Encephalomyelitis • Subacute sclerosing panencephalitis (SSPE) • Pregnancy Risks: • Infection during pregnancy can lead to congenital malformations in the fetus. Measles Virus DIAGNOSIS • Serologic Analysis: • Detection of IgM and IgG antibodies in patient serum. • Nucleic Acid Detection: • NAAT for viral RNA and nucleic acid sequencing to distinguish between vaccine reactions and wild-type infections. • IgG avidity assays can assist in confirming measles cases. • Cell Culture using respiratory, oropharyngeal, conjunctival samples, blood and urine specimens (as the virus is shed in urine) Measles Virus TREATMENT/PREVENTION • No antiviral drugs • Supportive care • Live attenuated trivalent vaccine MMR (2 doses: 1st dose- 12-15 months of age, 2nd dose-4-6 years of age) • Community immunization-herd immunity Respiratory Syncytial Virus Respiratory Syncytial Virus • G: Pneumovirus • RSV is the leading cause of acute lower respiratory tract infections in children under 5 years globally and poses serious risks for adults over 65. • lacks a hemagglutinin and does not bind to sialic acid and therefore does not need or have a neuraminidase • The virus has an F (fusion) protein that facilitates the fusion of host cells, leading to the formation of syncytial cells, which are indicative of RSV infection. • MOT: respiratory secretions Respiratory Syncytial Virus TREATMENT/PREVENTION • No vaccine is currently available for RSV prophylaxis. • Passive immunization with anti-RSV immunoglobulin is available for premature infants • Treatment is supportive, consisting of the administration of oxygen, intravenous fluids, and nebulized cold steam Human Parainfluenza Virus Human Parainfluenza Virus • HPIVs commonly cause upper and lower respiratory illnesses in infants, young children, older adults, and people with weakened immune systems, but anyone can get infected. • Subtypes: • Parainfluenza 1: Most common cause of croup. • Parainfluenza 3: Second in prevalence to RSV; associated with severe disease and fatalities. Most children infected by age 2. • Parainfluenza 4: Causes respiratory infections but not croup. • Adult Infections: Parainfluenza 1 and 3 can cause severe pulmonary infections requiring hospitalization. • Immunocompromised Patients: Significant morbidity and mortality. Human Parainfluenza Virus • Incubation period; 2-6 days • Symptoms are similar to the common cold • More serious illness in children •croup •Bronchitis •bronchiolitis •Pneumonia Mumps Virus Mumps Virus • contagious disease caused by a virus that affects the salivary glands • MOT: respiratory droplets from cough or sneezing, as well as through direct contact with saliva from an infected person • Incubation period: 2-4 weeks • Initial Symptoms: Mild symptoms may include headache, fever, fatigue, and loss of appetite. • Parotitis: The hallmark symptom is swelling of the parotid glands, which can cause puffy cheeks and a tender, swollen jaw. This swelling typically peaks within 1 to 3 days. • Complications: Severe complications can include: • Encephalitis (inflammation of the brain) • Orchitis (swelling of the testicles) • Hearing loss Mumps Virus DIAGNOSIS • Serological Tests-IgM and IgG detection • Molecular Tests-RT-PCR • Viral Culture TREATMENT/PREVENTION • No specific antiviral treatment • Symptomatic relief • Avoid aspirin • MMR vaccine Nipah and Hendra Virus • Nipah virus, was isolated from patients after an outbreak of severe encephalitis in Malaysia and Singapore in 1998 ✓More closely related to the Hendra virus, discovered in 1994 in Australia, than to other paramyxoviruses • Both viruses have broad host ranges, including pigs, man, dogs, horses, cats, and other mammals • Nipah virus, the reservoir is a fruit bat (flying fox) • Disease signs include flulike symptoms, seizures, and coma (269 cases occurring in 1999,108 were fatal) • Another epidemic in Bangladesh in 2004 had a higher mortality rate